Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The effect of antenatal depression and antidepressant treatment on placental tissue: a protein-validated gene expression study.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Reproductive Health.ORCID iD: 0000-0002-6246-7218
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Reproductive Health.ORCID iD: 0000-0003-4329-6721
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Reproductive Health.ORCID iD: 0000-0002-2112-8674
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Medicinsk genetik och genomik.
Show others and affiliations
2019 (English)In: BMC Pregnancy and Childbirth, ISSN 1471-2393, E-ISSN 1471-2393, Vol. 19, article id 479Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Antenatal depression affects 10-20% of pregnant women. Around 2-4% of European pregnant women use antidepressant treatment, most commonly selective serotonin reuptake inhibitors (SSRIs). Poor pregnancy outcomes, such as preterm birth and low birth weight, have been described in women with antenatal depression and in pregnant women on SSRI treatment. However, the effects of antenatal depression and antidepressant treatment on the placenta are largely unknown. The aim of this work was to compare placental gene and protein expression in healthy women, women with untreated antenatal depression and women on antidepressant treatment during pregnancy.

METHODS: Placental samples from 47 controls, 25 depressed and 45 SSRI-treated women were analysed by means of qPCR using custom-designed TaqMan low-density arrays (TLDAs) for 44 genes previously known to be involved in the pathophysiology of depression, and expressed in the placenta. Moreover, placental protein expression was determined by means of immunohistochemistry in 37 healthy controls, 13 women with untreated depression and 21 women on antidepressant treatment. Statistical comparisons between groups were performed by one-way ANOVA or the Kruskal-Wallis test.

RESULTS: Nominally significant findings were noted for HTR1A and NPY2R, where women with untreated depression displayed higher gene expression than healthy controls (p < 0.05), whereas women on antidepressant treatment had similar expression as healthy controls. The protein expression analyses revealed higher expression of HTR1A in placentas from women on antidepressant treatment, than in placentas from healthy controls (p < 0.05).

CONCLUSION: The differentially expressed HTR1A, both at the gene and the protein level that was revealed in this study, suggests the involvement of HTR1A in the effect of antenatal depression on biological mechanisms in the placenta. More research is needed to elucidate the role of depression and antidepressant treatment on the placenta, and, further, the effect on the fetus.

Place, publisher, year, edition, pages
2019. Vol. 19, article id 479
Keywords [en]
Antenatal depression, Antidepressant treatment, Immunohistochemistry, Placental gene expression, Placental protein expression, Selective serotonin reuptake inhibitors, TaqMan low-density array
National Category
Obstetrics, Gynecology and Reproductive Medicine
Identifiers
URN: urn:nbn:se:uu:diva-404635DOI: 10.1186/s12884-019-2586-yISI: 000511434300009PubMedID: 31805950OAI: oai:DiVA.org:uu-404635DiVA, id: diva2:1395966
Funder
Swedish Research Council, VR:521-2013-2339Available from: 2020-02-25 Created: 2020-02-25 Last updated: 2020-03-11Bibliographically approved

Open Access in DiVA

fulltext(1280 kB)318 downloads
File information
File name FULLTEXT01.pdfFile size 1280 kBChecksum SHA-512
a55d496b9fb5ed07ec0194d2b1a3120fb93711ebca5bf4871374e0686a451f5d457062456b1faf780321b0d3e55ac95da8bc7a0e7b4154556da435d5159a944b
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records

Edvinsson, ÅsaHellgren, CharlotteKallak, Theodora KunovacÅkerud, HelenaSkalkidou, AlkistisLager, SusanneSundström Poromaa, Inger

Search in DiVA

By author/editor
Edvinsson, ÅsaHellgren, CharlotteKallak, Theodora KunovacÅkerud, HelenaSkalkidou, AlkistisLager, SusanneSundström Poromaa, Inger
By organisation
Reproductive HealthMedicinsk genetik och genomikObstetrics and Reproductive Health Research
In the same journal
BMC Pregnancy and Childbirth
Obstetrics, Gynecology and Reproductive Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 320 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 190 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf